September 28 - Oct 1, 2014
Sheraton New Orleans Hotel
New Orleans, Louisiana, USA
Abstract submission deadline: Monday, July 21
Advance registration deadline: Monday, August 18
Concurrent Sessions 1-210:00 a.m.-11:45 a.m.
Concurrent Session 1: Computational Science: Leveraging Computer Data for Large Data SetsSession Chairperson: Yu Shyr, Vanderbilt-Ingram Cancer Center, Nashville, Tenn.
Big challenges of big data: Biomedical science in the petabyte eraYu Shyr
Instrumenting the healthcare enterprise for discovery researchShawn N. Murphy, Massachusetts General Hospital, Boston, Mass.
Risk stratified cancer screening and the Big DataArash Naeim, University of California, Los Angeles, Calif.
Concurrent Session 2: Behaviors That Keep Us HealthySession Chairperson: Kathleen Y. Wolin, Loyola University Chicago School of Medicine, Chicago, Ill.
Is it too late or too little? Prevention through physical activity Kathleen Y. Wolin
Research on establishing policies for comprehensive UV protectionDavid Buller, Kelin Buendel, Inc., Golden, Colo.
Knowledge, attitudes, and uptake of breast cancer chemoprevention in a multi-ethnic cohort of high-risk womenMeghna S. Trivedi, Columbia University Medical Center, New York, N.Y.*
Quitting or switching? Health benefits and risk of electronic cigarettesMaciej L. Goniewicz, Roswell Park Cancer Institute, Buffalo, N.Y.
Professional Advancement Session Supported by Susan G. Komen®11:45 a.m.-1:00 p.m.Session Chairperson: Waun Ki Hong, The University of Texas MD Anderson Cancer Center, Houston, Texas
Box lunches will be provided. Participation in this session is restricted to predoctoral or medical students and postdoctoral students or physicians-in-training. Click here for more information.To preregister for this session, please click here.
Waun Ki Hong
Mary L. (Nora) Disis, University of Washington, Seattle, Wash.
Barnett S. Kramer, National Cancer Institute-DCP, Bethesda, Md.
Concurrent Sessions 3-41:00 p.m.-2:40 p.m.
Concurrent Session 3: Implementation ScienceSession Chairperson: Jaye L. Viner, Curis, Inc., Lexington, Mass.
Dissemination and implementation of cancer prevention policies: The example of smoke-free public housingAnn C. Klassen, Drexel University School of Public Health, Philadelphia, Pa.
Incorporating patient reported data into clinical decision making: The example of rectal cancer surgeryLarissa K. F. Temple, Memorial Sloan Kettering Cancer Center, New York, N.Y.
Improving decision-making for ductal carcinoma in situRinaa S. Punglia, Harvard Medical School Center for Outcomes & Policy Research, Dana-Farber Cancer Institute, Boston, Mass. Concurrent Session 4: Harnessing the Immune System for Cancer PreventionSession Chairperson: Augusto C. Ochoa, Louisiana State University Health Sciences Center, New Orleans, La.
IntroductionAugusto C. Ochoa
Multi-antigen vaccines for cancer preventionMary L. (Nora) Disis, University of Washington, Seattle, Wash.
High-priority immunotherapy agents in development to treat and prevent cancer Martin A. (Mac) Cheever, Fred Hutchinson Cancer Center, Seattle, Wash.
Costimulation and coinhibition in preventing tumor progressionLieping Chen, Yale University, New Haven, Conn.
Plasma 25-hydroxyvitamin D and risk of colorectal cancer according to lymphocytic reaction and tumor-infiltrating T-cell subsets Mingyang Song, Harvard School of Public Health, Boston, Mass.*
Concurrent Sessions 5-62:50 p.m.-4:30 p.m.
Concurrent Session 5: Combinatorial Approaches to ChemopreventionSession Chairperson: Scott M. Lippman, UCSD Moores Cancer Center, La Jolla, Calif.
Targeting genetic drivers as an approach for combination chemopreventionScott M. Lippman
Exploiting aspirin's mechanism of action for combination chemopreventionAndrew T. Chan, Massachusetts General Hospital, Boston, Mass.
Cooperation between a rexinoid and EGFR-TKI for lung cancer prevention via Cyclin D1 destabilizationEthan Dmitrovsky, The University of Texas MD Anderson Cancer Center, Houston, Texas
Targeting multiple cell cycle regulatory points for the prevention of triple-negative breast cancerPowel H. Brown, The University of Texas MD Anderson Cancer Center, Houston, Texas*
Concurrent Session 6: Screening Controversies: Breast, Lung, and EsophagealSession Chairperson: Barnett S. Kramer, National Cancer Institute-DCP, Bethesda, Md.
Overview of cancer screening principles Barnett S. Kramer
Breast cancer screening: Moving toward more informed decision makingOtis W. Brawley, American Cancer Society, Atlanta, Ga.
Lung cancer screening: From efficacy to effectivenessDenise R. Aberle, David Geffen School of Medicine atUCLA, Los Angeles, Calif.
Disease dynamics: Cancers evolving fast and slow or not at allBrian J. Reid, Fred Hutchinson Cancer Research Center, Seattle, Wash.
Opening Plenary Session6:00 p.m.-7:30 p.m.
Welcome and Opening RemarksPhillip A. Dennis
A patient’s perspective on cancer and cancer preventionRalph R. Maggi, Lumasero Nano-Imaging Corporation, Midlothian, Va.
Report on the AACR Metformin Clinical Trials WorkshopPhillip A. Dennis
Distinguished Lecture on Targets for Cancer Prevention:Targeting oncogenic alterations of metabolismChi Van Dang, Abramson Cancer Center of University of Pennsylvania, Philadelphia, Pa.
Opening Reception7:30 p.m.-9:00 p.m.
*Short talks from proffered abstracts